Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · October 08, 2022

Extended Follow-Up Outcomes of PCI With Everolimus-Eluting Stents vs CABG for Multivessel CAD



Additional Info

Disclosure statements are available on the authors' profiles:

Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-up Outcomes of Multicenter Randomized Controlled BEST Trial
Circulation 2022 Sep 19;[EPub Ahead of Print], JM Ahn, DY Kang, SC Yun, SH Hur, HJ Park, D Tresukosol, WC Kang, HM Kwon, SW Rha, DS Lim, MH Jeong, BK Lee, H Huang, YH Lim, JH Bae, BO Kim, TK Ong, SG Ahn, CH Chung, DW Park, SJ Park

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading